ArticleDiscover oncology2025

Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer.

Nadia Najafizade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.